BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15518895)

  • 1. Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury.
    Farkas O; Tamás A; Zsombok A; Reglodi D; Pál J; Büki A; Lengvári I; Povlishock JT; Dóczi T
    Regul Pept; 2004 Dec; 123(1-3):69-75. PubMed ID: 15518895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postinjury administration of pituitary adenylate cyclase activating polypeptide (PACAP) attenuates traumatically induced axonal injury in rats.
    Tamás A; Zsombok A; Farkas O; Reglödi D; Pál J; Büki A; Lengvári I; Povlishock JT; Dóczi T
    J Neurotrauma; 2006 May; 23(5):686-95. PubMed ID: 16689670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats.
    Thornton E; Vink R; Blumbergs PC; Van Den Heuvel C
    Brain Res; 2006 Jun; 1094(1):38-46. PubMed ID: 16697978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttraumatic administration of pituitary adenylate cyclase activating polypeptide in central fluid percussion injury in rats.
    Kövesdi E; Tamás A; Reglodi D; Farkas O; Pál J; Tóth G; Bukovics P; Dóczi T; Büki A
    Neurotox Res; 2008 Apr; 13(2):71-8. PubMed ID: 18515209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.
    Reglodi D; Lubics A; Tamás A; Szalontay L; Lengvári I
    Behav Brain Res; 2004 May; 151(1-2):303-12. PubMed ID: 15084446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
    Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
    Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice.
    Ohtaki H; Dohi K; Yofu S; Nakamachi T; Kudo Y; Endo S; Aruga T; Goto N; Watanabe J; Kikuyama S; Shioda S
    Regul Pept; 2004 Dec; 123(1-3):61-7. PubMed ID: 15518894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice].
    Takeda N; Murozono M; Watanabe S; Isshiki A; Watanabe Y
    Masui; 2005 Mar; 54(3):240-8. PubMed ID: 15794099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals.
    Reglodi D; Fábián Z; Tamás A; Lubics A; Szeberényi J; Alexy T; Tóth K; Márton Z; Borsiczky B; Rõth E; Szalontay L; Lengvári I
    Regul Pept; 2004 Dec; 123(1-3):51-9. PubMed ID: 15518893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier.
    Nonaka N; Shioda S; Banks WA
    Exp Neurol; 2005 Jan; 191(1):137-44. PubMed ID: 15589520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyethylene glycol treatment after traumatic brain injury reduces beta-amyloid precursor protein accumulation in degenerating axons.
    Koob AO; Borgens RB
    J Neurosci Res; 2006 Jun; 83(8):1558-63. PubMed ID: 16555285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of the immunophilin ligand FK506 differentially attenuates neurofilament compaction and impaired axonal transport in injured axons following diffuse traumatic brain injury.
    Marmarou CR; Povlishock JT
    Exp Neurol; 2006 Feb; 197(2):353-62. PubMed ID: 16297913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous administration of PACAP alleviates traumatic brain injury in rats through a mechanism involving the TLR4/MyD88/NF-κB pathway.
    Mao SS; Hua R; Zhao XP; Qin X; Sun ZQ; Zhang Y; Wu YQ; Jia MX; Cao JL; Zhang YM
    J Neurotrauma; 2012 Jul; 29(10):1941-59. PubMed ID: 22583372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes.
    Shieh PC; Tsao CW; Li JS; Wu HT; Wen YJ; Kou DH; Cheng JT
    Neurosci Lett; 2008 Mar; 434(1):1-5. PubMed ID: 18313848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury.
    Okonkwo DO; Povlishock JT
    J Cereb Blood Flow Metab; 1999 Apr; 19(4):443-51. PubMed ID: 10197514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anorexigenic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: feeding-induced changes in the expression of mRNAs for PACAP and its receptors in the brain, and locomotor response to central injection.
    Matsuda K; Maruyama K; Miura T; Uchiyama M; Shioda S
    Neurosci Lett; 2005 Sep; 386(1):9-13. PubMed ID: 15975713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of progesterone on neurologic and morphologic outcome following diffuse traumatic brain injury in rats.
    O'Connor CA; Cernak I; Johnson F; Vink R
    Exp Neurol; 2007 May; 205(1):145-53. PubMed ID: 17362936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse effects of intrathecal pituitary adenylate cyclase-activating polypeptide on nociceptive transmission in mice spinal cord.
    Shimizu T; Katahira M; Sugawara H; Inoue K; Miyata A
    Regul Pept; 2004 Dec; 123(1-3):117-22. PubMed ID: 15518901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats.
    Reglödi D; Lubics A; Kiss P; Lengvári I; Gaszner B; Tóth G; Hegyi O; Tamás A
    Neuropeptides; 2006 Aug; 40(4):265-74. PubMed ID: 16904179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats.
    Reglodi D; Tamás A; Lubics A; Szalontay L; Lengvári I
    Regul Pept; 2004 Dec; 123(1-3):85-94. PubMed ID: 15518897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.